Clinical trials
Shock, Cardiogenic trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 15 |
| Unknown status | 12 |
| Not yet recruiting | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Hospital, Nancy, France | 10 |
| University Hospital, Montpellier | 7 |
| Assistance Publique - Hôpitaux de Paris | 6 |
| University Hospital, Strasbourg, France | 5 |
| Assistance Publique Hopitaux De Marseille | 3 |
| University Hospital, Bordeaux | 3 |
| CMC Ambroise Paré | 2 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| French Cardiology Society | 2 |
| Hospices Civils de Lyon | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Cardiogenic | 61 |
| Heart Failure | 6 |
| Shock | 5 |
| Heart Arrest | 4 |
| Myocardial Infarction | 4 |
| Respiratory Distress Syndrome | 4 |
| Shock, Septic | 3 |
| Acute Kidney Injury | 2 |
| Cardiac Output, Low | 2 |
| Infections | 2 |
Trials
Showing 51 to 61 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.